Skip to contentU
Ultralife Corp
U
ULBIUltralife Corp Q1 2024 · 10-Q
Revenue$41.93M$41.93M+31.4% vs Q1 2023 Net Income$2.89M$2.89MN/M vs Q1 2023 EPS Diluted$0.08$0.08+166.7% vs Q1 2023 Gross Profit$11,470,000+54.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ultralife Corp · CIK 875657 · Engraved from SEC EDGAR
Operating Cash Flow-$81,000N/M Free Cash Flowderived-$453,000N/M Margins · derivedGross margin27.4%+4.1 pt vs Q1 2023
Operating margin9.7%+9.6 pt vs Q1 2023
Net margin6.9%+8.0 pt vs Q1 2023
ended Mar 31, 2024 · filed Apr 25, 2024 · 25 d after period end